Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
A Multinational, Multicenter, Retrospective, Observational Drug Utilisation Study of Seroquel Extended Release (XR) Prescribed by Psychiatrists as Treatment for Major Depressive Disorder (MDD) in Selected Countries in the European Union (EU)
Age
18–120
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provision of informed consent before initiation of any collection of questionnaire data.
Documented clinical diagnosis of Major Depressive Disorder, Single Episode, or Recurrent.
Initiation of Seroquel XR for treatment of MDD during the period defining the inception cohort, i.e. from 3 months after launch until the index date (12 months after launch).
You may not be if
If participating in any clinical trial during the time from 3 months after launch until the index date, the patient cannot take part in this study.
